Biography:Iris Long
Iris Long | |
|---|---|
| Born | Iris Lillian Doerr December 8, 1934 New York City , New York, U.S. |
| Alma mater | Hunter College (B.A., M.A.) University of Connecticut (Ph.D.) |
| Known for | HIV/AIDS activism |
| Scientific career | |
| Fields | Organic chemistry, antiviral drugs |
| Institutions | Memorial Sloan Kettering Cancer Center Long Island Jewish Medical Center |
| Thesis | Lactones as Possible Carcinogens and Tumor Inhibitors (1972) |
| Doctoral advisor | Robert E. Willette |
Iris Lillian Doerr Long (born December 8, 1934) is an American chemist and activist in the AIDS Coalition to Unleash Power (ACT UP) effort to spread information about the possible Antiviral drugs that could be used to combat HIV/AIDS.
Education and career
Iris Lillian Doerr Long was born December 8, 1934, in New York City , New York. Her family was of German descent. At Hunter College, she completed a bachelor of arts in 1955 and a master of arts in chemistry in 1964.[1][2] Long worked as an organic chemist in several research hospitals, including eleven years at Sloan-Kettering, there she worked on developing nucleosides - experience that would later help her understand the workings of ARV drugs. She left Sloan-Kettering and earned her doctor of philosophy in 1972 at the University of Connecticut. Her dissertation was titled Lactones as Possible Carcinogens and Tumor Inhibitors. Long's doctoral advisor was Robert E. Willette.[2] After her doctoral studies, Long worked briefly at Long Island Jewish Medical Center. She later ceased working professionally as a chemist, and was acting as a stay at home carer for her mother, who was unwell. It was during this time that she became aware of the AIDS crisis and the potential use of drugs similar to those she had worked on to treat it.[1]
Activism
Despite having no connection to the gay community, or HIV/AIDS sufferers, Long began to volunteer with the Community Research Initiative (CRI), distributing drugs that could possibly help against the virus to those infected. Many of the drugs being taken were anti-cancer drugs. However, around March 1987 she attended a meeting of ACT-UP and was struck by the group's approach.[3] She brought the group information on a clinical trial carried out on HIV positive patients by the National Institute of Allergy and Infectious Disease (NIAID) and was able to explain the types of drugs being used. This proved to be her greatest gift; explaining the complex range of drugs out there to the group. Following this she helped for the Treatment and Data Committee to review medical information and report back to the larger group.[4] She would go on to organize the AIDS Treatment Registry.[5]
Personal life
She is married to Michael G. Long.[2]
See also
- List of AIDS activists
- Women in chemistry
References
- ↑ 1.0 1.1 Schulman, Sarah (May 16, 2003). "Interview of Iris Long May 16, 2003". Mix – the New York Lesbian & Gay Experimental Film Festival: 2.
- ↑ 2.0 2.1 2.2 Doerr, Iris Lillian (1972). "Lactones as Possible Carcinogens and Tumor Inhibitors". Doctoral Dissertations (University of Connecticut): 1–136. https://opencommons.uconn.edu/dissertations/AAI7232139.
- ↑ Schulman, Sarah (May 16, 2003). "Interview of Iris Long May 16, 2003". Mix – the New York Lesbian & Gay Experimental Film Festival: 2.
- ↑ Brier, Jennifer (2011). Infectious Ideas: U.S. Political Responses to the AIDS Crisis. Chapel Hill, NC: The University of North Carolina Press. p. 163. ISBN 978-0807872116.
- ↑ Lambert, Bruce (September 8, 1989). "Hospital Policy Is Said to Hurt AIDS Patients". The New York Times. https://www.nytimes.com/1989/09/08/nyregion/hospital-policy-is-said-to-hurt-aids-patients.html.
External links
 |  |
